Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial

[1]  E. Shpall,et al.  Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies , 2006, Bone Marrow Transplantation.

[2]  I. Millán,et al.  Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor. , 2006, Haematologica.

[3]  Arnon Nagler,et al.  Chelatable cellular copper modulates differentiation and self-renewal of cord blood-derived hematopoietic progenitor cells. , 2005, Experimental hematology.

[4]  K. Cornetta,et al.  Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT). , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  J. Wagner,et al.  Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. , 2004, The New England journal of medicine.

[6]  M. Labopin,et al.  Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. , 2004, The New England journal of medicine.

[7]  A. Nagler,et al.  Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. , 2004, Cytotherapy.

[8]  A. Nagler,et al.  Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice. , 2004, Experimental hematology.

[9]  Pingfu Fu,et al.  Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. , 2003, Blood.

[10]  J. Kurtzberg,et al.  Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. , 2003, Blood.

[11]  E. Shpall,et al.  Cord blood transplantation , 2002 .

[12]  J Wagner,et al.  Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. , 2002, Blood.

[13]  Chan Zeng,et al.  Transplantation of ex vivo expanded cord blood. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  A. Nagler,et al.  Erratum: Cellular copper content modulates differentiation and self-renewal in cultures of cord blood-derived CD34+ cells (British Journal of Haematology 116:3 (655-661)) , 2002 .

[15]  J. Wagner,et al.  Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. , 2001, The New England journal of medicine.

[16]  J. Wagner,et al.  Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. , 2001, The New England journal of medicine.

[17]  P. Rubinstein,et al.  Placental blood for bone marrow replacement: the New York Blood Center's program and clinical results. , 2000, Bailliere's best practice & research. Clinical haematology.

[18]  C. Chastang,et al.  Outcome of cord-blood transplantation from related and unrelated donors , 1997 .

[19]  C. Chastang,et al.  Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. , 1997, The New England journal of medicine.

[20]  A. Deisseroth,et al.  Tacrolimus and Minidose Methotrexate for Prevention of Acute Graft- Versus-Host Disease After Matched Unrelated Donor Marrow Transplantation , 1996 .

[21]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.